(Q36974311)

English

Phase I study of a herpes simplex virus type 2 (HSV-2) DNA vaccine administered to healthy, HSV-2-seronegative adults by a needle-free injection system

scientific article published on 10 September 2008

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Phase I study of a herpes simplex virus type 2 (HSV-2) DNA vaccine administered to healthy, HSV-2-seronegative adults by a needle-free injection system (English)

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Human herpesvirus 2

1 reference

based on heuristic

inferred from title

9

object named as

Lawrence Corey

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

3

object named as

Anna Wald

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

object named as

David M Koelle

10

0 references

Ashok Cattamanchi

1

object named as

Ashok Cattamanchi

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Christine M Posavad

2

object named as

Christine M Posavad

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

author name string

Yaela Baine

4

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Jennifer Moses

5

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Terry J Higgins

6

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Richard Ginsberg

7

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Richard Ciccarelli

8

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

publication date

10 September 2008

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Clinical and Vaccine Immunology

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

15

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

11

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

1638-1643

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Induction of HIV-specific functional immune responses by a multiclade HIV-1 DNA vaccine candidate in healthy Ugandans

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2583522

29 September 2017

Safety and immunogenicity of a Gag-Pol candidate HIV-1 DNA vaccine administered by a needle-free device in HIV-1-seronegative subjects

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2583522

29 September 2017

Phase 1 safety and immunogenicity evaluation of a multiclade HIV-1 DNA candidate vaccine

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2583522

29 September 2017

A DNA vaccine for Ebola virus is safe and immunogenic in a phase I clinical trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2583522

29 September 2017

Diversity of the CD8+ T-cell response to herpes simplex virus type 2 proteins among persons with genital herpes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2583522

29 September 2017

Current developments in viral DNA vaccines: shall they solve the unsolved?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2583522

29 September 2017

The effects of herpes simplex virus-2 on HIV-1 acquisition and transmission: a review of two overlapping epidemics

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2583522

29 September 2017

Neonatal herpes simplex infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2583522

29 September 2017

CD4 T-cell responses to herpes simplex virus type 2 major capsid protein VP5: comparison with responses to tegument and envelope glycoproteins

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2583522

29 September 2017

A comparison of biodegradable microparticles and MF59 as systemic adjuvants for recombinant gD from HSV-2.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2583522

29 September 2017

Clearance of HSV-2 from recurrent genital lesions correlates with infiltration of HSV-specific cytotoxic T lymphocytes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2583522

29 September 2017

Severe genital herpes infections in HIV-infected individuals with impaired herpes simplex virus-specific CD8+ cytotoxic T lymphocyte responses

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2583522

29 September 2017

Herpes simplex virus infection of human fibroblasts and keratinocytes inhibits recognition by cloned CD8+ cytotoxic T lymphocytes.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2583522

29 September 2017

Antigenic specificities of human CD4+ T-cell clones recovered from recurrent genital herpes simplex virus type 2 lesions.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2583522

29 September 2017

Comparison of Western blot (immunoblot) and glycoprotein G-specific immunodot enzyme assay for detecting antibodies to herpes simplex virus types 1 and 2 in human sera

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2583522

29 September 2017

Human CD8+ herpes simplex virus-specific cytotoxic T-lymphocyte clones recognize diverse virion protein antigens

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2583522

29 September 2017

DNA-based immunization

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2583522

27 June 2018

Humoral and cellular immune responses to herpes simplex virus-2 glycoprotein D generated by facilitated DNA immunization of mice.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2583522

27 June 2018

Interferon-gamma enhances resolution of herpes simplex virus type 2 infection of the murine genital tract

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2583522

27 June 2018

Baculovirus-expressed herpes simplex virus type 2 glycoprotein D is immunogenic and protective against lethal HSV challenge

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2583522

27 June 2018

Clinical safety and efficacy of a powdered Hepatitis B nucleic acid vaccine delivered to the epidermis by a commercial prototype device.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2583522

4 September 2018

Effects of DNA immunization formulated with bupivacaine in murine and guinea pig models of genital herpes simplex virus infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2583522

4 September 2018

T lymphocytes are required for protection of the vaginal mucosae and sensory ganglia of immune mice against reinfection with herpes simplex virus type 2.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2583522

4 September 2018

Glycoprotein-D–Adjuvant Vaccine to Prevent Genital Herpes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2583522

4 December 2018

Co-immunization with plasmids coding the full length and a soluble form of glycoprotein D of HSV-2 induces protective cellular and humoral immune response in mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/18784341

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

T Cell Immunity to Herpes Simplex Viruses in Seronegative Subjects: Silent Infection or Acquired Immunity?

1 reference

https://pubmed.ncbi.nlm.nih.gov/18784341

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Immunogenicity and efficacy of a new recombinant DNA vaccine for hepatitis B virus in Peru]

1 reference

https://pubmed.ncbi.nlm.nih.gov/18784341

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

DNA immunization with HIV early genes in HIV type 1-infected patients on highly active antiretroviral therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/18784341

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Humoral immune response to HSV-1 and HSV-2 viral proteins in patients with primary genital herpes

1 reference

https://pubmed.ncbi.nlm.nih.gov/18784341

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The adjuvant combination monophosphoryl lipid A and QS21 switches T cell responses induced with a soluble recombinant HIV protein from Th2 to Th1

1 reference

https://pubmed.ncbi.nlm.nih.gov/18784341

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Recombinant glycoprotein vaccine for the prevention of genital HSV-2 infection: two randomized controlled trials. Chiron HSV Vaccine Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/18784341

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Synergistic copathogens--HIV-1 and HSV-2

1 reference

https://pubmed.ncbi.nlm.nih.gov/18784341

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1128/CVI.00167-08

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36974311&oldid=1746220813"